Prosthetic Heart Valves: A Global Strategic Business Report
San Jose, California (PRWEB) July 03, 2014
Follow us on LinkedIn. – Prosthetic heart valves are used for replacing malfunctioning, deformed or diseased native heart valves in order to restore normal functioning of the heart. Aging population, changing lifestyles and growing prevalence of other diseases such as hypertension and cholesterol are driving the prevalence of heart valve disorders. This in turn is fueling the volume of heart valve replacement procedures performed each year, worldwide. Mechanical heart valve represents the conventional form of prosthetic heart valve, which continues to be used despite their decline in popularity in developed countries. Indicated mainly for use in younger patient population due to their high durability, these valves are relatively cheaper but necessitate the use of anticoagulants. Biological or tissue heart valves, on the other hand, have been witnessing strong demand, since these valves do not require long-term anticoagulation therapy. However, concerns over durability, higher prices and risk of side effects such as precipitation of related cardiac complications continue to limit adoption of tissue heart valves.
Prosthetic heart valves market has been witnessing significant technological advances, which are enabling manufacturers to develop highly effective, durable devices with better hemodynamics, thus contributing to growth in demand. Development of durable tissue heart valves, and suture-less valves as well as anti-calcification technologies are expected to push revenues in the market. A major advancement in the area of prosthetic heart valves is the emergence of transcatheter aortic valve implantation (TAVI) wherein implantation is carried out through a minimally invasive, catheter based surgical procedure. The technology expands the target patient population eligible for valve replacement procedures, encompassing even patients with severe aortic stenosis. The ongoing trend towards minimally invasive surgeries is expected to drive demand for TAVI procedures in the coming years and in turn spur demand for prosthetic valves. Significant unmet needs in the global heart valve replacement space are also expected to drive demand for TAVI.
As stated by the new market research report on Prosthetic Heart Valves, Europe and the United States continue to dominate the global market. As pioneers in heart valve technologies, these markets have been the epicenter of significant technology advancements. The United States represents the single largest market with growth supported by strong demand for new and advanced products, along with high prevalence and incidence of cardiac disorders. Asia-Pacific ranks as the fastest growing market with a CAGR of 7.8% over the analysis period. Robust economic growth particularly China and India, improving access to healthcare, increase in diagnosis of cardiovascular diseases, high incidence of rheumatic heart disease (RHD), developing healthcare infrastructure, and growing per capita healthcare spends, represent factors driving growth in the region.
Major players covered in the report include Edwards Lifesciences Corporation, JenaValve Technology Inc., Medtronic Inc., On-X Life Technologies Inc., Sorin Group and St. Jude Medical Inc.
The research report titled "Prosthetic Heart Valves: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, drivers, mergers, acquisitions and other strategic industry activities of major companies. The report provides market estimates and projections for geographic markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America) and Rest of World. The report also analyzes the global and regional prosthetic heart valves markets (excluding Transcatheter Heart Valves) by the following product segments – Tissue Heart Valves and Mechanical Heart Valves. In addition, the report separately analyzes the global Transcatheter Aortic Valve Implantation (TAVI) systems for geographic markets including US, Japan, Europe and Rest of World.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Prosthetic_Heart_Valves_Market_Report.asp.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/